Literature DB >> 6773868

Tumoral calcinosis. Observations during six years.

E Leicht, H J Tkocz, H Seeliger, T Lauffenburger, H G Haas.   

Abstract

Findings of a 56 year old woman suffering from tumoral calcinosis, who was treated for 6 years, are presented. Under conditions known to lead to negative calcium-phosphorus balance, a reduction in tumor size was seen. Transient hypercalcemia was attributed to immobilization. The process of tumor reduction was not definitely accelerated by treatment with ethane-hydroxy-diphosphonate (EHDP; 500 mg/day for 20 months). Nephrotic syndrome as a consequence of amyloidosis developed. Amyloidosis seems to have resulted from the aseptic histiocytic inflammatory process in the tumors. The possible importance of high cholesterol in very low density lipoproteins in the serum of the patient is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773868     DOI: 10.1055/s-2007-996264

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

Review 1.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

Review 2.  Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.

Authors:  Lisal J Folsom; Erik A Imel
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

3.  Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates.

Authors:  Karthik Balachandran; Sadishkumar Kamalanathan; Jaya Prakash Sahoo; Ashok Kumar Das; Dhanapathi Halanaik
Journal:  Indian J Endocrinol Metab       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.